Hyperactivation of Nrf2 leads to hypoplasia of bone in vivo
Open Access
- 15 March 2018
- journal article
- research article
- Published by Wiley in Genes to Cells
- Vol. 23 (5) , 386-392
Abstract
Keap1 is a negative regulator of Nrf2, a master transcription factor that regulates cytoprotection against oxidative and electrophilic stresses. Although several studies have suggested that the Keap1‐Nrf2 system contributes to bone formation besides the maintenance of redox homeostasis, how Nrf2 hyperactivation by Keap1 deficiency affects the bone formation remains to be explored, as the Keap1‐null mice are juvenile lethal. To overcome this problem, we used viable Keap1‐deficient mice that we have generated by deleting the esophageal Nrf2 in Keap1‐null mice (NEKO mice). We found that the NEKO mice exhibit small body size and low bone density. Although nephrogenic diabetes insipidus has been observed in both the NEKO mice and renal‐specific Keap1‐deficient mice, the skeletal phenotypes are not recapitulated in the renal‐specific Keap1‐deficient mice, suggesting that the skeletal phenotype by Nrf2 hyperactivation is not related to the renal phenotype. Experiments with primary culture cells derived from Keap1‐null mice showed that differentiation of both osteoclasts and osteoblasts was attenuated, showing that impaired differentiation of osteoblasts rather than osteoclasts is responsible for bone hypoplasia caused by Nrf2 hyperactivation. Thus, we propose that the appropriate control of Nrf2 activity by Keap1 is essential for maintaining bone homeostasis.Keywords
Funding Information
- Japan Society for the Promotion of Science (17K15590, 26111002, 26111010, 26460354)
- Japan Agency for Medical Research and Development (CREST, chronic inflammation)
This publication has 27 references indexed in Scilit:
- Toward clinical application of the Keap1–Nrf2 pathwayTrends in Pharmacological Sciences, 2013
- Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiationJournal of Clinical Investigation, 2010
- Nrf2: friend or foe for chemoprevention?Carcinogenesis, 2009
- N‐acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cellsJournal of Cellular Biochemistry, 2007
- Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2Molecular and Cellular Biology, 2004
- Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κBBiochemical and Biophysical Research Communications, 2004
- Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activationNature Genetics, 2003
- Oxidative stress modulates osteoblastic differentiation of vascular and bone cellsFree Radical Biology and Medicine, 2001
- Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting ProteinJournal of Biological Chemistry, 2001
- Corticosteroids and Fractures: A Close Encounter of the Third Cell KindJournal of Bone and Mineral Research, 2000